Neuronetics Inc (STIM)

Currency in USD
3.030
-0.180(-5.61%)
Closed·
2.980-0.050(-1.65%)
·
Advertisement

Neuronetics (STIM) Earnings Dates & Reports

Latest Release
11/08/2026
EPS / Forecast
-0.05 / -0.12
Revenue / Forecast
41.57M / 40.11M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2026--/-0.113--/40.88M----Free Sign Up
06/2026-0.050/-0.12041.57M/40.11M+58.33%+3.64%Free Sign Up
03/2026-0.160/-0.13034.50M/34.18M-23.08%+0.94%Free Sign Up
12/2025-0.100/-0.09041.77M/40.66M-11.11%+2.73%Free Sign Up
09/2025-0.130/-0.13021.80M/37.85M0%-42.4%Free Sign Up
06/2025-0.150/-0.08038.11M/36.59M-87.5%+4.15%Free Sign Up
03/2025-0.210/-0.19031.98M/29.07M-10.53%+10.01%Free Sign Up
12/2024-0.330/-0.24022.50M/18.97M-37.5%+18.61%Free Sign Up
09/2024-0.440/-0.23018.53M/19.14M-91.3%-3.19%Free Sign Up
06/2024-0.330/-0.27016.45M/18.65M-22.22%-11.8%Free Sign Up

All numbers in USD

Neuronetics Inc Earnings Call Summary for Q2/2026

  • Neuronetics Q2 loss of 5¢/share beat estimates by 7¢; revenue rose 9.1% to $41.6M, topping forecasts by $1.5M; shares surged 22.58% premarket.
  • Gross margin expanded to 61.1% from 46.6% YoY; adjusted EBITDA turned positive at $0.3M vs. -$5.6M prior year, signaling profitability progress.
  • Greenbrook clinic revenue jumped 16.8% to $26.9M, while NeuroStar revenue fell 2.7% to $14.7M amid commercial model transition to purchase/lease options.
  • FY2026 guidance narrowed to $160-164M revenue; raised gross margin outlook to 48-50%; cut operating expenses to $95-100M from $100-105M prior range.
  • Company targets limited net cash use in H2 2026; expanding platform for multiple therapies including TMS, SPRAVATO, and future psychedelic treatments.
Last Updated: 11/08/2026, 14:22
Read Full Transcript

FAQ

What Is Neuronetics's Earnings Per Share (TTM)?

The Neuronetics EPS for trailing twelve months (TTM) is -0.437.

When Is The Next Neuronetics (STIM) Earnings Date?

Neuronetics will release its next earnings report on 10/11/2026, according to their financial calendar.

What Is Neuronetics’s Revenue Forecasts For Upcoming Quarters?

Neuronetics’s revenue forecast is 40.88M.

How Did Neuronetics Share Price React to the Company's Latest Earnings Report Results?

Neuronetics reported a +58.33% EPS surprise and a +3.64% revenue surprise, when comparing the latest STIM earnings report against analyst forecasts. The stock price changed by 47.930%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.